Momenta Pharmaceuticals, Inc. (MNTA)

[tekcor_atnm]

MNTA: TA, Tracking the performance of my predictions

On March 26th MNTA was at $14.56 and I posted that it could hit $18 - $20 in two months (#msg-61391185). Now, exactly two months later, MNTA hit a high of $20 (to the penny), the highest level since mEnoxaparin approval in July 2010. The move from $14.56 to $20.00 represents a +37% gain.

Going forward, I am predicting that MNTA will at least double from the $18 level to $36 in 2011 (#msg-62899596). In addition, my analysis indicates that ultimately MNTA could triple to quadruple from current levels within 2 years.